atovaquone oral suspension
Generic: atovaquone
Labeler: kvk-tech, inc.Drug Facts
Product Profile
Brand Name
atovaquone oral suspension
Generic Name
atovaquone
Labeler
kvk-tech, inc.
Dosage Form
SUSPENSION
Routes
Active Ingredients
atovaquone 750 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
10702-223
Product ID
10702-223_116f0b5b-cbad-8216-e063-6294a90a9a13
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210510
Listing Expiration
2026-12-31
Marketing Start
2019-03-29
Pharmacologic Class
Established (EPC)
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
10702223
Hyphenated Format
10702-223
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
atovaquone oral suspension (source: ndc)
Generic Name
atovaquone (source: ndc)
Application Number
ANDA210510 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/5mL
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (10702-223-21) / 210 mL in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "116f0b5b-cbad-8216-e063-6294a90a9a13", "openfda": {"nui": ["N0000175482", "N0000175485"], "upc": ["0310702223219"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["b31ff20a-c363-4be0-9bc0-3081c163b63c"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["KVK-Tech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (10702-223-21) / 210 mL in 1 BOTTLE, PLASTIC", "package_ndc": "10702-223-21", "marketing_start_date": "20190329"}], "brand_name": "Atovaquone Oral Suspension", "product_id": "10702-223_116f0b5b-cbad-8216-e063-6294a90a9a13", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "10702-223", "generic_name": "Atovaquone", "labeler_name": "KVK-Tech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone Oral Suspension", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA210510", "marketing_category": "ANDA", "marketing_start_date": "20190329", "listing_expiration_date": "20261231"}